Related Experiment Video

Updated: Aug 20, 2026

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
05:18

Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome

Published on: May 26, 2023

Treatment of a central giant cell granuloma with intralesional corticosteroid

Evandro Neves Abdo1, Luiz César Fonseca Alves, Alessandra Sabrina Rodrigues

  • 1Department of Oral Surgery and Pathology, Faculty of Odontologia, School of Dentistry, Federal University of Minas Gerais, Av.: Antônio Carlos, 6627 sala 3204, Belo Horizonte, Minas Gerais, CEP 31270901, Brazil. enabdo@bol.com.br

The British Journal of Oral & Maxillofacial Surgery
|December 29, 2004
PubMed

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...